home / stock / kne:cc / kne:cc news

KNE:CC News and Press, Kane Biotech Inc. From 02/06/23

Stock Information
Company Name: Kane Biotech Inc.
Stock Symbol: KNE:CC
Market: TSXVC
Website: kanebiotech.com
Menu
KNE:CC KNE:CC Quote KNE:CC Short KNE:CC News KNE:CC Articles KNE:CC Message Board
Get KNE:CC Alerts

News, Short Squeeze, Breakout and More Instantly...
KNE:CC - Kane Biotech Announces Extension of Term of Credit Facility

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, Feb. 06, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) announces today that it has entered into an amending agre...
KNE:CC - Kane Biotech Announces First Distribution Agreement for its coactiv+(TM) Antimicrobial Hydrogel

WINNIPEG, Manitoba, Jan. 04, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces today that it has recently signed a distribution agreement with Salud Pharma S.A. (“Salud Pharma”) for its coactiv+...

KNE:CC - Kane Biotech Announces Loan Transaction

WINNIPEG, Manitoba, Dec. 29, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has reached an agreement to obtain loans (the “Loans”) in the aggregate amount of $2,000,000 from t...

KNE:CC - Kane Biotech Announces Third Quarter 2022 Financial Results

WINNIPEG, Manitoba, Nov. 24, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announced its third quarter 2022 financial results. Financial Highlights: Total revenue for the three months ...
KNE:CC - Kane Biotech to Release Third Quarter 2022 Financial Results on November 24, 2022 - Conference Call to Follow

WINNIPEG, Manitoba, Nov. 17, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and re...

KNE:CC - Kane Biotech Announces 510(k) Submission for its coactiv+(TM) Antimicrobial Hydrogel

WINNIPEG, Manitoba, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) announces that it has recently submitted a 510(k) premarket notification, which has been received by The Center for Devices and Radio...

KNE:CC - Kane Biotech to Present at Symposium on Advanced Wound Care Fall Forum

WINNIPEG, Manitoba, Oct. 13, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that the Company will be presenting at the Symposium on Advanced Wound Care (SAWC) Fall forum. The conference w...
KNE:CC - Kane Biotech Receives an Additional $425K USD of Funding for its DispersinB® Hydrogel from the United States Department of Defense

WINNIPEG, Manitoba, Oct. 04, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”) today announces that it has received an additional $425,000 USD of funding for its DispersinB Hydrogel ® related to its Med...

KNE:CC - Kane Biotech to Release Second Quarter 2022 Financial Results on August 25, 2022 - Conference Call to Follow

WINNIPEG, Manitoba, Aug. 18, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development and commercialization of technologies and products that prevent and r...

KNE:CC - Kane Biotech Announces Adoption of Amended and Restated Stock Option Plan and Performance and Restricted Share Unit Plan

Not for distribution to U.S. news wire services or dissemination in the United States WINNIPEG, Manitoba, June 30, 2022 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE) (the “Company” or “Kane Biotech”) announces that, following the approval of the share...
Previous 10 Next 10